Please login to the form below

Not currently logged in
Email:
Password:

KOL Strategy

This page shows the latest KOL Strategy news and features for those working in and with pharma, biotech and healthcare.

New accounts: September

Aranesp KOL strategy. Oncology. central. Amgen European HQ. Mimpara meetings. Nephrology. ... central. Amgen European HQ. Neulasta KOL strategy. Oncology. central. Baxter Healthcare UK.

Latest news

  • New accounts: October

    Amgen European HQ. Aranesp KOL strategy. Oncology. central. Amgen European HQ. ... Mimpara meetings. Nephrology. central. Amgen European HQ. Neulasta KOL strategy. Oncology.

  • New accounts: November

    Allergan. Botox. Neurology. Jango Communications. Amgen European HQ. Aranesp KOL strategy. ... Neulasta KOL strategy. Oncology. central. GlaxoSmithKline. Cervarix. Cervical cancer (consumer healthcare).

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics